Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income	Preferred stock	Accumulated deficit
Beginning Balance at Jun. 30, 2021	$ 10,581	$ 33	$ 106,821	$ 21	$ 14,931	$ (111,225)
Beginning Balance, shares at Jun. 30, 2021		32,740,000
Issuance of shares and warrants - net of issue costs	13,634	$ 7	13,627
Issuance of shares and warrants - net of issue costs, shares		7,200,000
Conversion of Series C Preferred stock to common stock		$ 1	1,255		(1,256)
Conversion of Series C preferred stock to common stock, shares		1,467,000
Exercise of 2020 Investor Warrants for cash	69		69
Exercise of 2020 Investor Warrants for Cash, shares		69,000
Exercise of pre-funded warrants for cash	5	$ 5
Exercise of pre-funded warrants for cash, shares		4,800,000
Warrants issued for services	31		31
Stock option expense	811		811
Series A Preferred cash dividend	(2)					(2)
Series C Preferred stock dividend		$ 2	2,460			(2,462)
Series C Preferred stock dividend, shares		1,698,000
Loss for the period	(5,966)					(5,966)
Ending Balance at Sep. 30, 2021	19,163	$ 48	125,074	21	13,675	(119,655)
Ending Balance, shares at Sep. 30, 2021		47,974,000
Beginning Balance at Jun. 30, 2022	11,795	$ 66	135,510	21	12,554	(136,356)
Beginning Balance, shares at Jun. 30, 2022		65,533,000
Issuance of shares and warrants - net of issue costs	1,903	$ 13	1,890
Issuance of shares and warrants - net of issue costs, shares		13,100,000
Stock option expense	518		518
Series A Preferred cash dividend	(2)					(2)
Series C Preferred stock dividend		$ 2	360			(362)
Series C Preferred stock dividend, shares		2,174,000
Loss for the period	(4,596)					(4,596)
Ending Balance at Sep. 30, 2022	$ 9,618	$ 81	$ 138,278	$ 21	$ 12,554	$ (141,316)
Ending Balance, shares at Sep. 30, 2022		80,807,000